Ronald Gress, MD
Enriched profileChief and Senior Investigator, Experimental Transplantation and Immunotherapy Branch · National Cancer Institute (NIH)
Ronald Gress is Chief and Senior Investigator, Experimental Transplantation and Immunotherapy Branch at National Cancer Institute (NIH). OpenAlex indexes 484 publications with 31,095 citations (h-index 78); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Ronald E. Gress, MD, is Chief and Senior Investigator, Experimental Transplantation and Immunotherapy Branch at National Cancer Institute (NIH), Center for Cancer Research. The public record shows 484 publications with 31,095 citations (h-index 78), centered on Leukemia (AML/ALL/CML/CLL), Bladder / Urothelial Cancer, Lymphoma. It also documents an investigator role on 11 registered clinical trials.
- Most recent indexed publication: 2016 · The Journal of experimental medicine
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 11 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD
Sponsor: National Cancer Institute (NCI)
- Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
Sponsor: National Cancer Institute (NCI)
- Providing Access to Cord Blood Units for Transplants
Sponsor: National Cancer Institute (NCI)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Systemic toxoplasma infection triggers a long-term defect in the generation and function of naive T lymphocytes.
The Journal of experimental medicine
Article2016
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/ronald-gress-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
ccr.cancer.gov/news/article/clinical-trial-to-test-drug-for-cancer-patients-with-weakened-immune-systems
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ccr.cancer.gov ↗ - Other
ccr.cancer.gov/news/milestones-2023/new-faculty
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ccr.cancer.gov ↗ - LinkedIn
LinkedIn: Ronald Gress, Branch Chief, National Cancer Institute (NCI)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
- Internal medicine residency
Johns Hopkins Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗ - Oncology fellowship
Johns Hopkins Hospital and National Cancer Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗
Editorial & leadership roles
journal and society appointments- Chief
Experimental Transplantation and Immunotherapy Branch (ETIB), Center for Cancer Research, NCI
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grantome.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nihrecord.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.